health
April 29, 2026
Revolutionary Discovery: Key Differences in Brains Resisting Alzheimer's
Brain changes associated with Alzheimer's disease most often lead to a severe decline in memory and cognitive functions – but this is not the rule in every case.

TL;DR
- Approximately 20-30% of older adults have asymptomatic Alzheimer's disease (ASYMAD), with brain pathology but no cognitive decline.
- A new study identified chromogranin A (CgA) as a key protein in a genetic network linked to Alzheimer's.
- Mice lacking CgA developed Alzheimer's pathology but remained cognitively normal.
- Female mice lacking CgA showed even fewer signs of brain damage compared to males.
- Researchers speculate hormonal, immune, or genetic differences between sexes may explain this disparity.
- Understanding natural resistance mechanisms and regulating CgA could lead to new Alzheimer's therapies.
Continue reading the original article